<bill session="119" type="s" number="1096" updated="2025-07-21T19:32:26Z">
  <state datetime="2025-04-03">REPORTED</state>
  <status>
    <unknown datetime="2025-04-03"/>
  </status>
  <introduced datetime="2025-03-24"/>
  <titles>
    <title type="short" as="introduced">Preserve Access to Affordable Generics and Biosimilars Act</title>
    <title type="short" as="reported to senate">Preserve Access to Affordable Generics and Biosimilars Act</title>
    <title type="display">Preserve Access to Affordable Generics and Biosimilars Act</title>
    <title type="official" as="introduced">A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.</title>
  </titles>
  <sponsor bioguide_id="K000367"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2025-03-24"/>
    <cosponsor bioguide_id="B001288" joined="2025-03-24"/>
    <cosponsor bioguide_id="C001096" joined="2025-03-24"/>
    <cosponsor bioguide_id="D000563" joined="2025-03-24"/>
    <cosponsor bioguide_id="E000295" joined="2025-03-24"/>
    <cosponsor bioguide_id="G000386" joined="2025-03-24"/>
    <cosponsor bioguide_id="K000377" joined="2025-03-24"/>
    <cosponsor bioguide_id="W000800" joined="2025-03-24"/>
  </cosponsors>
  <actions>
    <action datetime="2025-03-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2025-03-24" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
    <action datetime="2025-04-03" state="REPORTED">
      <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2025-04-10">
      <text>Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2025-04-10" calendar="Senate Legislative" under="General Orders" number="46">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 46.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Reported By, Markup By, Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Civil actions and liability"/>
    <term name="Competition and antitrust"/>
    <term name="Contracts and agency"/>
    <term name="Federal Trade Commission (FTC)"/>
    <term name="Intellectual property"/>
    <term name="Judicial review and appeals"/>
    <term name="Licensing and registrations"/>
    <term name="Manufacturing"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
</bill>
